Insulet (NASDAQ:PODD) Coverage Initiated at Royal Bank of Canada
Royal Bank of Canada started coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a research report released on Thursday, Marketbeat Ratings reports. The firm issued an outperform rating and a $340.00 price objective on the medical instruments supplier’s stock. Other analysts also recently issued reports about the stock. Piper Sandler increased their price […]
Royal Bank of Canada started coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a research report released on Thursday, Marketbeat Ratings reports. The firm issued an outperform rating and a $340.00 price objective on the medical instruments supplier’s stock. Other analysts also recently issued reports about the stock. Piper Sandler increased their price […]
